Federal Minister of health, Jens Spahn (CDU) does not want to touch controversial assumption of Costs for homeopathic medicinal products by health insurance companies. He referred on Tuesday evening in Berlin, the “Berliner Salon” of the editorial network in Germany that the statutory funds in the case of Drug expenditure of around 40 billion euros in the year paid around 20 million for homeopathy. You could discuss emotionally and many before the head bump. Or one could ask whether it is in the light of the total order value. He had decided it was “okay”.
In Germany, it is discussed about the topic vigorously. Who wants to have such means, should you get, “but please not at the expense of the community of solidarity”, said the head of the kassenärztliche bundesvereinigung (KBV), Andreas streets, recently. He referred to not sufficient scientific evidence for the effectiveness of homeopathic remedies.
SPD parliamentary group Deputy Karl Lauterbach sees it the same: He wants to. statutory health insurance, the reimbursement of homeopathy prohibit “We need to talk in the Grand coalition about that,” he said.
Homeopathy is not part of the power catalogue of statutory health insurance. However, refund a lot of funds Insured person the cost of treatment for natural remedies, because there is a demand. This is also a tool in the competitive struggle.
In France a decision has been made: There the homeopathic medicinal products should no longer be reimbursed to ab 2021. The Supreme health authority (HAS) has been tested according to its own information, for nine months, almost 1200 homeopathic medicines and more than 1000 scientific publications is analyzed. In the end, the authority came to the conclusion that efficacy cannot be demonstrated. The HAS also pointed out that the use of homeopathy in serious progressive diseases shall not delay medically necessary treatment.
The current reimbursement of 30 percent of the cost in France is first lowered in the year to 15 percent. 2021 then it should be no assumption of costs more. Health Minister Agnès Buzyn, said that the transition phase should give both the patient as well as the industry time to prepare.